Method of producing sugar chain using human G4 polypeptide
View Patent ↗The present invention provides a novel polypeptide having a β1,3-N-acetylglucosaminyl transferase activity; a method for producing the polypeptide; a DNA which encodes the polypeptide; a recombinant vector into which the DNA is inserted; a transformant comprising the recombinant vector; a method for producing a sugar chain or complex carbohydrate, using the polypeptide; a method for producing a sugar chain or complex carbohydrate, using the transformant; an antibody which recognizes the polypeptide; a method for screening a substance which changes the expression of the gene which encodes the polypeptide; and a method for screening a substance which changes the activity of the polypeptide.
1. A method for synthesizing a sugar chain which comprises the step of: introducing DNA or RNA into a cell, wherein said cell comprises an acceptor substrate selected from i) N-acetyllactosamine (Galβ1-4GlcNAc), Galβ1-3GlcNAc or lactose (Galβ1-4Glc), ii) an oligosaccharide having an N-acetyllactosamine, Galβ1-3GlcNAc or lactose structure at the non-reducing end, and iii) a complex carbohydrate having an N-acetyllactosamine, Galβ1-3GlcNAc or lactose structure at the non-reducing terminal, wherein said DNA or RNA encodes a polypeptide selected from the group consisting of the following (a) and (b), and having β1,3-N-acetylglucosaminyltransferase activity:
(a) a polypeptide comprising the amino acid sequence of SEQ ID NO:2; and
(b) a polypeptide comprising the amino acid sequence of positions 45-372 of SEQ ID NO:2; and
culturing the cell to express the polypeptide.
2. A method for synthesizing a sugar chain which comprises the step of: introducing DNA or RNA into a cell, wherein said cell comprises an acceptor substrate selected from i) N-acetyllactosamine (Galβ1-4GlcNAc), Galβ1-3GlcNAc or lactose (Galβ1-4Glc), ii) an oligosaccharide having an N-acetyllactosamine, Galβ1-3GlcNAc or lactose structure at the non-reducing end, and iii) a complex carbohydrate having an N-acetyllactosamine, Galβ1-3GlcNAc or lactose structure at the non-reducing terminal, wherein said DNA or RNA encodes a polypeptide comprising an amino acid sequence having 95% or more homology with a polypeptide selected from the group consisting of the following (a) and (b), and having β1,3-N-acetylglucosaminyltransferase activity:
(a) a polypeptide comprising the amino acid sequence of SEQ ID NO:2; and
(b) a polypeptide comprising the amino acid sequence of positions 45-372 of SEQ ID NO:2; and
culturing the cell to express the polypeptide.
3. The method according to claim 1 or 2 , wherein the β1,3-N-acetylglucosaminyltransferase activity is an activity of transferring N-acetylglucosamine to a galactose residue present in the non-reducing terminal of said acceptor substrate via a β1,3 linkage.